Back to Search Start Over

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis

Source :
Plus Company Updates. November 19, 2024
Publication Year :
2024

Abstract

ROCKVILLE: AURINIA PHARMACEUTICALS INC has issued the following news release: Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) commends the American College of Rheumatology (ACR) for their 2024 evidence-based [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Plus Company Updates
Publication Type :
News
Accession number :
edsgcl.816667386